J K Pharmachem Ltd Financial Statement

As of Apr 4, 2026, J K Pharmachem Ltd has a market capitalization of - Cr. Value Research classifies it as a Mega-Cap company.

Yes, J K Pharmachem Ltd is not with a debt-to-equity ratio of .

In FY 2025 , J K Pharmachem Ltd recorded a total revenue of approximately - Cr marking a significant milestone in the company's financial performance.

J K Pharmachem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising annually..

J K Pharmachem Ltd's current PE ratio is .

J K Pharmachem Ltd's ROCE averaged NaN% from the FY ending March NaN to NaN, with a median of NaN%. It peaked at -Infinity% in March NaN, reflecting strong capital efficiency over the period..

J K Pharmachem Ltd's latest EBIT is Rs. - Cr, surpassing the average EBIT of Rs. - Cr over the 5 years..